Fig. 2 | Scientific Reports

Fig. 2

From: Effect of trimetazidine on left ventricular functions and cardiac biomarkers in diabetic patients with left ventricular diastolic dysfunction: a randomized controlled trial

Fig. 2

Change in laboratory and clinical parameters after 3 months of intervention in TMZ and placebo groups. Data are presented as mean ± 2 standard error. LDL-C: low density lipoprotein. NT-proBNP: n- terminal pro brain natriuretic peptide. mMRC: modified medical research council. DBP: diastolic blood pressure. * p < 0.05 vs. placebo group. #p < 0.05 vs. baseline.

Back to article page